Product Description
Gemcitabine Injection IP refers to a medication containing the active ingredient gemcitabine hydrochloride, which is a chemotherapy drug used to treat various types of cancer. Gemcitabine is a nucleoside analog that interferes with the growth and spread of cancer cells in the body.
Gemcitabine is commonly used in the treatment of:
- Pancreatic cancer
- Non-small cell lung cancer
- Breast cancer
- Ovarian cancer
- Bladder cancer
- Soft tissue sarcoma
- Hodgkin's and non-Hodgkin's lymphoma
Gemcitabine is typically administered intravenously (IV) by a healthcare professional in a clinical setting. It works by disrupting the process of DNA synthesis in cancer cells, ultimately leading to their death.
As with any chemotherapy drug, gemcitabine may cause side effects, which can vary from person to person and depending on the dose and duration of treatment. Common side effects may include nausea, vomiting, fatigue, hair loss, decreased blood cell counts (leading to increased risk of infection, anemia, or bleeding), and flu-like symptoms.